×
The Investor Relations website contains information about Agios Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial ...
People also ask
Since our founding, Agios has been a pioneering leader in cellular metabolism, advancing therapies for patients with unmet needs. Our mature and unique ...
Christopher Taylor VP, Investor Relations and Corporate Communications Email: IR@agios.com. latest-earnings-call Latest Earnings Call View Replay.
Apr 18, 2024 · A live webcast of the presentation can be accessed under "Events & Presentations" in the Investors section of the company's website at www.agios ...
Agios Pharmaceuticals (AGIO) EHA Investor Presentation - Slideshow · SA TranscriptsFri, Jun. 18, 2021. Agios Pharmaceuticals, Inc. (AGIO) CEO Jacqualyn Fouse ...
Apr 18, 2024 · For more information, please visit the company's website at www.agios.com. Contacts: Investor Contact Chris Taylor, VP, Investor Relations and ...
23 hours ago · Analysts Estimate Agios Pharmaceuticals (AGIO) to Report a Decline in Earnings: What to Look Out for ... Investor Relations · Contact · Careers ...